Generation of asporogenous solventogenic clostridia
AssigneeUniversity of Delaware
InventorsEleftherios T. Papoutsakis, Daniel R. Hess, Bryan P. Tracy
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Delaware
InventorsEleftherios T. Papoutsakis, Daniel R. Hess, Bryan P. Tracy
Estimating the term…
Expression of the SpoIIE gene in a solventogenic Clostridium cell is silenced and sporulation is abolished. The cell exhibits increased production of a solvent, such as butanol, relative to a wild-type solventogenic Clostridium cell and can be used for industrial-scale production of a chemical product. A method includes silencing the SpoIIE gene of the Clostridium cell via a homologous recombination method in which a resolvase gene is expressed. Another method includes increasing solvent production in bacterial cells by inoculating the cells with an inoculum of exponentially growing cells, wherein expression of a sporulation gene in the bacterial cells is inhibited or silenced and the cells of the inoculum are in a post-exponential phase of growth prior to inoculation.
A Clostridium cell, wherein expression of the SpoIIE gene of said Clostridium cell is silenced.
A method for abolishing sporulation in a Clostridium cell comprising silencing the expression of the SpoIIE gene of the cell, wherein sporulation by the cell is abolished.
A method for increasing solvent production in bacterial cells, comprising inoculating a medium with an inoculum of the bacterial cells, wherein expression of a sporulation gene in the bacterial cells is inhibited or silenced, and wherein the bacterial cells of the inoculum are in a post-exponential phase of growth prior to inoculation.
Dependencies are inferred from the claim text.